Metraipolis › archive › dc_fab7be978013

Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist Candidates — Europe PMC PMID:42123416

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42123416
DOI
10.3390/ijms27093823
License (as archived)
solo-consultazione
Archived
2026-11-03T06:14:04.166Z
SHA-256 of the archived text
5ba1a156830c2678e854ab0de8ac4792dec89bb8b5e3e7c9823832c22db4d90b
Stable URL of this page
https://metraipolis.com/documento/dc_fab7be978013

How to cite

Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist Candidates — Europe PMC PMID:42123416 — Europe PMC (en), https://europepmc.org/article/MED/42123416 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fab7be978013 (Metraipolis archive dc_fab7be978013, sha256 5ba1a156830c2678e854ab0de8ac4792dec89bb8b5e3e7c9823832c22db4d90b)
BibTeX
@misc{dcfab7be978013,
  title = {Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist Candidates — Europe PMC PMID:42123416},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123416},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fab7be978013; sha256 5ba1a156830c2678e854ab0de8ac4792dec89bb8b5e3e7c9823832c22db4d90b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123416. Agents can read the archived copy with the MCP tool read_document.